Psychosis crisis associated with
thyrotoxicosis due to Graves' disease.
This delay was compounded by the following issues: 1) presence of bulbar palsy at the start of disease, in the absence of any ocular symptoms, 2) coexistence of bulbar and
thyrotoxicosis symptoms, and 3) history of multinodular adenomatous goiter and recent thyroid biopsy that mislead attention to thyroid disease complications, causing swelling of thyroid gland and obstructive symptoms.
Although a few treatment guidelines have been published, management of juvenile
thyrotoxicosis is controversial and often unsatisfactory (7,8,9).
Totally thirty patients with varied clinical presentations are confirmed to be suffering from the
thyrotoxicosis and tests were appropriately evaluated and
Thyrotoxicosis controlled, and consented patients were operated.
Amiodarone-induced
thyrotoxicosis type 2: a case report and review of the literature.
Another probable cause of valvulopathy is the hemodynamic changes in
thyrotoxicosis, including increased venous return and dilatation of cardiac chambers and valve annulus [2, 13].
During her hospital stay, she was started on oral naproxen and propranolol for the
thyrotoxicosis. Her urine drug screen was positive for tetrahydrocannabinol (THC).
Cortisol requirements are increased due to the stress and increased metabolic demands of
thyrotoxicosis. The mechanism of increased cortisol clearance appears to be due to thyroid hormone effects on the activity of 11[beta]HSD and 5-[alpha] reductase enzymes [4].
In 32 patients, the diagnosis of Graves' hyperthyroidism was based on the presence of symptoms and signs of
thyrotoxicosis, elevated serum-free thyroid hormones with suppressed serum thyroid-stimulating hormone (TSH) levels, and one or more specific clinical features including diffuse goiter with audible bruit, ophthalmopathy, and dermopathy.
Thyroid function tests showed a TSH of 0.02 U/mL, free T4 of 3.89 ng/dL, and free T3 of 5.1 pg/mL, consistent with
thyrotoxicosis. The patient was HIV negative and hepatitis C antibody positive.
The hungry bone syndrome after medical treatment of
thyrotoxicosis. Ann Intern Med 2003; 139: 706-7.
Among participants, 30 cases experienced
thyrotoxicosis again during the first six months after discontinuing anti-thyroid drug (ATD) sessions that had been carried out for at least 12 months prior to stopping (Relapse group).
It is reported that postoperative complications of parathyroidectomy for SHPT include hyperkalemia, hypocalcemia, local bleeding, and general complications of acute myocardial infarction and stroke.[sup][5] However, there have been few reports on
thyrotoxicosis as a postoperative complication of parathyroidectomy in SHPT patients with normal thyroid undergoing dialysis.
Many studies have revealed that
thyrotoxicosis causes bone diseases 2.
It is ordered primarily to help diagnose a form of hyperthyroidism called T3
thyrotoxicosis, in which only T3 is elevated.
